Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flu Headlines Challenge New FDA Heads

This article was originally published in The Pink Sheet Daily

Executive Summary

Peggy Hamburg and Josh Sharfstein were chosen because of their public health backgrounds. The flu outbreak in Mexico is an early test that should play right to their skills, but it may also change how they view their initial mandate.

You may also be interested in...



Flu Vaccine: Will H1N1 Spur Creation Of A Quadrivalent Seasonal Shot?

The H1N1 pandemic flu virus will be on the slate of candidates as influenza experts and government scientists debate the composition of the 2010-11 influenza vaccine

Flu Vaccine: Will H1N1 Spur Creation Of A Quadrivalent Seasonal Shot?

The H1N1 pandemic flu virus will be on the slate of candidates as influenza experts and government scientists debate the composition of the 2010-11 influenza vaccine

FDA Chief Scientist Goodman Spearheads Agency Response To Swine Flu

FDA acting chief scientist Jesse Goodman is taking the lead role in coordinating the agency's response to the swine flu outbreak

Related Content

Topics

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel